Published in Journal of the American Pharmacists Association : JAPhA
The purpose of this commentary is to describe the ideal role of 503B outsourcing facilities in the U.S. drug supply chain. We also address the challenges that 503B outsourcing facilities are facing that limit their utilization and offer possible solutions. Section 503B outsourcing facilities are emerging contributors in compounding owing to their a...
Published in Journal of the American Pharmacists Association : JAPhA
Coronavirus disease 2019 (COVID-19) has posed unprecedented challenges for nations worldwide, among which medication shortages can cause a devastatingly negative impact on global health. Using Taiwan as an example, this report describes the sources of potential medication shortages, discusses the preparedness and contingency strategies to address m...
Published in Journal of the American Pharmacists Association : JAPhA
The U.S. capacity to manufacture key essential medications has diminished. The U.S. pharmaceutical supply chain (USPSC) has diversified and now relies on international sources of active pharmaceutical ingredients and finished drug products (FDPs). Despite years of effort raising concerns about the USPSC, pharmacists and pharmacy technicians continu...
Published in Journal of the American Pharmacists Association : JAPhA
Pharmacists are among the nation's most accessible and underused health professionals. Within their scope of practice, pharmacists can prescribe and administer vaccines, conduct point-of-care testing, and address drug shortages through therapeutic substitutions. To better use pharmacists as first responders to coronavirus disease 2019 (COVID-19), w...
Published in Journal of the American Pharmacists Association : JAPhA
The Drug Quality and Security Act passed in 2013 created a new voluntary category of compounders, referred to as outsourcing facilities. The regulatory landscape allows these facilities to compound on a larger scale in comparison with the typical compounding pharmacies, which positions them to potentially serve a role in overcoming drug shortages. ...
Published in Journal of the American Pharmacists Association : JAPhA
Published in Journal of the American Pharmacists Association : JAPhA
Adderall (amphetamine-dextroamphetamine) is a controlled substance with harmful adverse effects if abused or misused. We assessed the availability of Adderall from common search engines, and evaluated the safety and marketing characteristics of online pharmacies selling Adderall. Cross-sectional study. From December 2019 to February 2020, the phras...
Published in Journal of the American Pharmacists Association : JAPhA
Pharmacists listen to and dispel medication misinformation daily. Because of their accessibility, pharmacists have the opportunity during pharmacist-patient interactions to begin a dialogue with their patients and provide critical education to improve patient safety and public health. Current examples of pharmacists intervening with medication misi...
Published in Journal of the American Pharmacists Association
The unprecedented changes brought about by the global COVID-19 pandemic have had significant impacts on society. It has provided an opportunity to highlight the crucial role pharmacists play in the provision of healthcare. The critical and unique role of pharmacists in pandemics and other disasters has been highlighted in the past (SARS and Ebola o...
Published in Journal of the American Pharmacists Association
Objective(s) To evaluate the frequency of nonmelanoma skin cancer (NMSC), NMSC precursors, and melanoma on a store-and-forward dermatology model featuring the pharmacist as the patient’s point-of-contact. The secondary objective was to define lesion changes and symptoms perceived by patients (clinical prediction rules by nonexpert observers) that c...
